SCHEMBL2530746

SCHEMBL2530746

Brc1ccccc1C1CCCCC1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.45
BRD4 O60885 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.42
HTR2C P28335 4/20 0.41
HTR2B P41595 4/20 0.41
MAP1LC3B Q9GZQ8 1/20 0.41
PTGS2 P35354 1/20 0.41
SLC6A2 P23975 2/20 0.40
HTR2A P28223 2/20 0.40
SLC6A4 P31645 2/20 0.40
SLC6A3 Q01959 1/20 0.40
BCHE P06276 1/20 0.38
ACHE P22303 1/20 0.38
MAPT P10636 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30626968 1.00 KDM1A (0.45) KDM1ABRD4PTGDR2HTR2CHTR2B
SCHEMBL10046437 0.88 KDM1A (0.50) KDM1ABRD4HTR2CHTR2BMAP1LC3B
SCHEMBL29427088 0.88 KDM1A (0.50) KDM1ABRD4HTR2CHTR2BMAP1LC3B
SCHEMBL42781 0.83 PTGDR2 (0.48) PTGDR2HTR2CPTGS2BCHEACHE
SCHEMBL779938 0.80 CHRNB4 (0.46) PTGDR2HTR2CPTGS2BCHEACHE
SCHEMBL19876804 0.79 CEL (0.36) KDM1APTGDR2PTGS2MAPT
SCHEMBL9510947 0.79 KDM4E (0.42) PTGDR2MAPT
SCHEMBL1483812 0.79 CEL (0.41) PTGDR2HTR2CPTGS2BCHEACHE
SCHEMBL5584663 0.78 KDM1A (0.42) KDM1ABRD4HTR2CHTR2BMAP1LC3B
SCHEMBL5584664 0.78 HTR2C (0.60) HTR2CSLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260033237-A1 AMINE COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING SAME SAMSUNG DISPLAY CO LTD (KR) 2026-01-29 US disclosed
US-12490647-B2 Amine compound and light-emitting device including same SAMSUNG DISPLAY CO., LTD. (KR) 2025-12-02 US disclosed
CN-119431102-A Halogenated cyclohexylbenzene compound and preparation method thereof 棓诺(张家港)新材料有限公司 2025-02-14 CN disclosed
US-20240224792-A1 AMINE-BASED COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE AMINE-BASED COMPOUND, AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS EACH INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-07-04 US disclosed
CN-118125925-A Amine-based compound, light-emitting device, electronic device, and electronic apparatus 三星显示有限公司 2024-06-04 CN disclosed
CN-114315726-B Preparation method of gem-difluoroallyl compound 中国科学院上海有机化学研究所 2024-02-09 CN disclosed
US-20240049593-A1 LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-02-08 US disclosed
CN-116916673-A Light emitting element and display device including the same 三星显示有限公司 2023-10-20 CN disclosed
US-20230157155-A1 LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-18 US disclosed
CN-116082168-A Light emitting device and amine compound for light emitting device 三星显示有限公司 2023-05-09 CN disclosed
EP-1534671-A2 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-06-01 EP disclosed
US-6888032-B2 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2005-05-03 US disclosed
US-20040138468-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2004-07-15 US disclosed
US-20040092507-A1 Melanocortin receptor agonists ELI LILLY AND COMPANY 2004-05-13 US disclosed
WO-2004013094-A2 COPPER-CATALYZED FORMATION OF CARBON-HETEROATOM AND CARBON-CARBON BONDS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2004-02-12 WO disclosed
EP-0291718-A1 Process for making meta-alkyl phenols ETHYL CORPORATION (US) 1988-11-23 EP disclosed
US-4774368-A Process for making meta-alkyl phenols ETHYL CORPORATION (US) 1988-09-27 US disclosed
EP-0074608-B1 LIQUID CRYSTAL HALOGEN COMPOUNDS, PROCESS FOR THEIR PREPARATION, DIELECTRIC AND DECTROOPTICAL DISPLAY ELEMENT CONTAINING THEM MERCK PATENT GmbH (DE) 1985-07-03 EP disclosed
US-4490305-A Liquid-crystalline halogen compounds, process for their preparation, dielectrics containing these, and electro-optical display element MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-12-25 US disclosed
EP-0074608-A2 Liquid crystal halogen compounds, process for their preparation, dielectric and dectrooptical display element containing them MERCK PATENT GmbH (DE) 1983-03-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040092507-A1 Melanocortin receptor agonists MC1R, MC4R, MC5R KDM1A 1917/4885BRD4 3602/4885PTGDR2 365/4885
US-20260033237-A1 AMINE COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING SAME HCN1, CRY1, NAT1 KDM1A 281/4885BRD4 84/4885PTGDR2 2551/4885
US-20040138468-A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds CBR3, TST, CBS KDM1A 1069/4885BRD4 581/4885PTGDR2 2341/4885
US-20240224792-A1 AMINE-BASED COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE AMINE-BASED COMPOUND, AND ELECTRONIC DEVICE AND ELECTRONIC APPARATUS EACH INCLUDING THE LIGHT-EMITTING DEVICE AADAT, SLC1A2, SAT1 KDM1A 408/4885BRD4 800/4885PTGDR2 1995/4885
US-20230157155-A1 LIGHT EMITTING DEVICE AND AMINE COMPOUND FOR LIGHT EMITTING DEVICE CRY1, SLC1A2, CHRM1 KDM1A 256/4885BRD4 1457/4885PTGDR2 1215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.